EMD-56479
SARM1 TIR with BEXi adduct 17
EMD-56479
Single-particle2.94 Å
Deposition: 25/01/2026Map released: 03/06/2026
Last modified: 03/06/2026
The rise and fall of SARM1 base-exchange inhibitors.
Lundback T
,
Chandrasekar V
,
Gu C,
Ju H,
McAdam R,
Palomero M,
Sader K,
Peter B
,
Wissler L,
Nevin P,
Foster E
,
Jamier T
,
Manjappa P
,
Johansson C
,
Sandmark J,
Ding M
,
Persson-Kry A,
Mitra S,
Munise Satir T,
Bilican B,
Messa M,
Fraser G,
Linley J,
Plant H,
Moore R
,
Seifert T,
Lerche M,
Raynochek C,
Nilsson E,
Majbour N,
Lucey R,
Maia de Oliveira T,
Wang Q
,
Chessell I,
Breccia P,
Jarvis R
(2026) Commun Chem , 9
,
Chandrasekar V
,
Gu C,
Ju H,
McAdam R,
Palomero M,
Sader K,
Peter B
,
Wissler L,
Nevin P,
Foster E
,
Jamier T
,
Manjappa P
,
Johansson C
,
Sandmark J,
Ding M
,
Persson-Kry A,
Mitra S,
Munise Satir T,
Bilican B,
Messa M,
Fraser G,
Linley J,
Plant H,
Moore R
,
Seifert T,
Lerche M,
Raynochek C,
Nilsson E,
Majbour N,
Lucey R,
Maia de Oliveira T,
Wang Q
,
Chessell I,
Breccia P,
Jarvis R
(2026) Commun Chem , 9
Grant Support:
- Other private: AstraZeneca (United Kingdom)
